Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
BMC Neurology|February 2, 2018
The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosisTilman Hottenrott, Rick Dersch, Benjamin Berger, et al.
Journal of Neurology|November 14, 2018
Admission diagnoses of patients later diagnosed with autoimmune encephalitisAnnette Baumgartner, Sebastian Rauer, Tilman Hottenrott, et al.
German Medical Science : GMS E-Journal|April 29, 2020
Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosisSebastian Rauer, Stephan Kastenbauer, Heidelore Hofmann, et al.
Cells|December 1, 2020
Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple SclerosisTilman Robinson, Ahmed Abdelhak, Tanima Bose, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 26, 2018
Primary intraspinal non-Hodgkin's lymphoma: Case report and review of literatureLena-Alexandra Beume, Katharina Wolf, Horst Urbach, et al.
Journal of Neurology|March 8, 2018
The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosisTilman Hottenrott, Elisabeth Schorb, Kristina Fritsch, et al.
BMC Psychiatry|August 2, 2015
Hypoglutamatergic state is associated with reduced cerebral glucose metabolism in anti-NMDA receptor encephalitis: a case reportDominique Endres, Evgeniy Perlov, Oliver Stich, et al.
Journal of Neuroimmunology|August 14, 2023
Steroid-responsive encephalopathy associated with autoimmune thyroiditis presenting as cortisone sensible psychosis with reversible leukoencephalopathyKimon Runge, Sebastian Rauer, Elena Waibel, et al.
Frontiers in Immunology|April 4, 2019
The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral InvolvementNils Venhoff, Jens Thiel, Marta Rizzi, et al.
Frontiers in Neurology|April 12, 2019
Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?Ahmed Abdelhak, Tilman Hottenrott, Estrella Morenas-Rodríguez, et al.
Pageof 8